Muscle Dysmorphia and the use of anabolic steroids: a scoping review
DOI:
https://doi.org/10.53843/bms.v10i14.743Keywords:
Transtornos Dismórficos CorporaisAbstract
INTRODUCTION: This study aimed to map the scientific production on the non-medical use of anabolic steroids and its relationship with muscle dysmorphia, vigorexia, and body dysmorphic disorder (BDD) in physical exercise practitioners, in order to identify gaps and evidence hints. METHODS: The elaboration of this scoping review followed the PRISMA-ScR checklist and was conducted in five stages: 1) Formulation of the research question using the PCC method; 2) Selection of databases and delineation of search strategies; 3) Export of retrieved studies to Rayyan and establishment of eligibility criteria; 4) Selection of articles by two independent and blinded reviewers; 5) Construction of an evidence table, according to the JBI model. RESULTS: Six areas of the relationship between muscle dysmorphia and the use of anabolic steroids were analyzed: 1) terminologies used to describe the disorder of chronic dissatisfaction with muscular shape; 2) participant recruitment sites; 3) research instruments used to assess muscle dysmorphia; 4) evaluated populations, dividing them into: male, female, and mixed population; 5) motivations associated with the use of anabolic steroids; 6) average time of steroid use in the sample. DISCUSSION: Although there were variations in the research instruments used, it was identified that cultural and aesthetic motivations emerge as pillars of the correlation between the use of anabolic steroids and muscle dysmorphia, creating a pathological scenario that demands new research on the subject. CONCLUSIONS: A bidirectional relationship between the use of anabolic steroids and muscle dysmorphia was observed, as well as the predominance of studies involving male populations and highlighting the tangency of aesthetic motivations for the use of these substances. However, it is essential to expand research on the subject to ensure the generalization of the findings.
Metrics
References
REFERÊNCIAS
- Nieschlag E, Nieschlag S. ENDOCRINE HISTORY: The history of discovery, synthesis and development of testosterone for clinical use. European Journal of Endocrinology. 2019 Jun;180(6):R201–12. DOI: https://doi.org/10.1530/EJE-19-0071
- De Almeida FE. Esteróides anabolizantes: história, mecanismos de funcionamento e efeitos colaterais. Revista Brasileira de Fisiologia do Exercício. 2010 Dec 10;9(4):266. DOI: https://doi.org/10.33233/rbfe.v9i4.3546
- Specter SE, Wiss DA. Muscle Dysmorphia: Where Body Image Obsession, Compulsive Exercise, Disordered Eating, and Substance Abuse Intersect in Susceptible Males. Eating Disorders, Addictions and Substance Use Disorders. 2014;439–57. DOI: https://doi.org/10.1007/978-3-642-45378-6_20
- Soares HLR, Gonçalves HCB. Transtorno Dismórfico Muscular. Fractal: Revista de Psicologia [Internet]. 2012 Apr;24 : 211–4. DOI: https://doi.org/10.1590/S1984-02922012000100015
- VELOZO, Dhara Luiza Francisconni Giolo, REIS, Maria Aparecida Inácio Dos , LANDIM, Leonardo Monteiro, SILVA, Tiago Dantas Reges Da. Vigorexia: Dismorfia corporal. Revista Científica Multidisciplinar Núcleo do Conhecimento. 2020. Ano 05, Ed. 12, Vol. 10, pp.
- Tricco, AC, Lillie, E, Zarin, W, O'Brien, KK, Colquhoun, H, Levac, D, Moher, D, Peters, MD, Horsley, T, Weeks, L, Hempel, S et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018,169(7):467-473. DOI: https://doi.org/10.7326/M18-0850
- Mattos SM, Cestari VRF, Moreira TMM. Scoping protocol review: PRISMA-ScR guide refinement. Rev Enferm UFPI. 2023 Mar 5;12(1). DOI: https://doi.org/10.26694/reufpi.v12i1.3062
- Descritores em Ciências da Saúde: DeCS [Internet]. ed. 2023. São Paulo (SP): BIREME / OPAS / OMS. 2023 [atualizado 2023 Dez 04; citado 2024, Março, 20].
- Aromataris E, Munn Z (Editors). JBI Manual for Evidence Synthesis. JBI. Published online 2020.
- Scarth M, Westlye LT, Havnes IA, Bjørnebekk A. Investigating anabolic-androgenic steroid dependence and muscle dysmorphia with network analysis among male weightlifters. BMC Psychiatry. 2023 Maio;23(1):342. DOI: https://doi.org/10.1186/s12888-023-04781-1
- Kanayama G, Pope HG, Cohane G, Hudson JI. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. Drug Alcohol Depend. 2003 Jul;71(1):77-86. DOI: https://doi.org/10.1016/S0376-8716(03)00069-3
- Olivardia R, Pope HG Jr, Hudson JI. Muscle dysmorphia in male weightlifters: a case-control study. Am J Psychiatry. 2000 Ago;157(8):1291-1296. DOI: https://doi.org/10.1176/appi.ajp.157.8.1291
- González-Martí I, Fernández-Bustos JG, Contreras Jordán OR, Sokolova M. Muscle dysmorphia: detection of the use-abuse of anabolic androgenic steroids in a Spanish sample. Adicciones. 2018 Abr;30(4):243-250. DOI: https://doi.org/10.20882/adicciones.853
- Pope HG Jr, Kanayama G, Hudson JI. Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biol Psychiatry. 2012 Fev;71(3):254-261. DOI: https://doi.org/10.1016/j.biopsych.2011.06.024
- Macedo, Arythan & Chaves Nunes Filho, Júlio César & Matos, Robson & Pinto, Daniel & Correia, Luís & Nunes, Marília. Relação da vigorexia com o uso de esteroides anabolizantes em praticantes de treinamento de força. Revista Brasileira de Nutrição Esportiva. 2019 Out;13. 733-738.
- Behar Rosa, Molinari Daniela. Dismorfia muscular, imagen corporal y conductas alimentarias en dos poblaciones masculinas. Rev. méd. Chile. 2010 Nov;138(11): 1386-1394. DOI: https://doi.org/10.4067/S0034-98872010001200007
- Giardino, Joseph & Procidano, Mary. Muscle Dysmorphia Symptomatology: A Cross-Cultural Study in Mexico and the United States. International Journal of Men's Health. 2012 Abr;11. 83-103. 10.3149/jmh.1101.83. DOI: https://doi.org/10.3149/jmh.1101.83
- Gruber AJ, Pope HG Jr. Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom. 2000;69(1):19-26. DOI: https://doi.org/10.1159/000012362
- Kanayama G, Barry S, Hudson JI, Pope HG Jr. Body image and attitudes toward male roles in anabolic-androgenic steroid users. Am J Psychiatry. 2006 Abr;163(4):697-703. DOI: https://doi.org/10.1176/ajp.2006.163.4.697
- Greenway, C., & Price, C. A qualitative study of the motivations for Anabolic-androgenic steroid use: the role of Muscle Dysmorphia and Self-esteem in Long-term users. Performance enhancement and health. 2018;6, 12-20. DOI: https://doi.org/10.1016/j.peh.2018.02.002
- Grogan S, Shepherd S, Evans R, Wright S, Hunter G. Experiences of anabolic steroid use: in-depth interviews with men and women body builders. J Health Psychol. 2006 Nov;11(6):845-856. DOI: https://doi.org/10.1177/1359105306069080
- Padulo J, Oliva F, Frizziero A, Maffulli N. Muscles, Ligaments and Tendons Journal - Basic principles and recommendations in clinical and field Science Research: 2016 Update. Muscles Ligaments Tendons J. 2016;6(1):1-5. DOI: https://doi.org/10.11138/mltj/2016.6.1.001
- Suffolk, M., Dovey, T., Goodwin, H., & Meyer, C. Muscle Dysmorphia: Methodological Issues, Implications for Research. Eating Disorders. 2013;21, 437 - 457. DOI: https://doi.org/10.1080/10640266.2013.828520
- Frederick DA, Fessler DM, Haselton MG. Do representations of male muscularity differ in men's and women's magazines?. Body Image. 2005 Mar;2(1):81-86. DOI: https://doi.org/10.1016/j.bodyim.2004.12.002
- Striegel-Moore RH, Bulik CM. Risk factors for eating disorders. Am Psychol. 2007 Abr;62(3):181-198. 1 DOI: https://doi.org/10.1037/0003-066X.62.3.181
- Pope HG Jr, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict. 2014 Jul;23(4):371-377. DOI: https://doi.org/10.1111/j.1521-0391.2013.12118.x
- Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr. Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications. Drug Alcohol Depend. 2010 Jun;109(1-3):6-13. DOI: https://doi.org/10.1016/j.drugalcdep.2010.01.011
- Bond P, Smit DL, de Ronde W. Anabolic-androgenic steroids: How do they work and what are the risks?. Front Endocrinol (Lausanne). 2022 Dez;13:1059473. DOI: https://doi.org/10.3389/fendo.2022.1059473
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Davi Ricardo Soares Gama de Amorim, Camillo Collier de Farias, Tomás de Aguiar Germani, Lucas Aires Araújo, Marcelo Jose da Cunha Portela, Giovanni Chiappetta Romero, Paulo Fernando Viegas Barros de Albuquerque, Gabriel Arcoverde de Siqueira Lindington Lins, Hugo Rafael de Souza e Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
User licenses define how readers and the general public can use the article without needing other permissions. The Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders can use to share original works of authorship and other material subjects to copyright and certain other rights specified in the public license available at https:// creativecommons.org/licenses/by/4.0/deed.pt_BR. Using the 4.0 International Public License, Brazilian Medical Students (BMS) grants the public permission to use published material under specified terms and conditions agreed to by the journal. By exercising the licensed rights, authors accept and agree to abide by the terms and conditions of the Creative Commons Attribution 4.0 International Public License.
